AAAAAA

   
Results: 1-3 |
Results: 3
THROMBOLYTIC THERAPY FOR PULMONARY-EMBOLISM - FREQUENCY OF INTRACRANIAL HEMORRHAGE AND ASSOCIATED RISK-FACTORS
Authors: KANTER DS MIKKOLA KM PATEL SR PARKER JA GOLDHABER SZ
Citation: Ds. Kanter et al., THROMBOLYTIC THERAPY FOR PULMONARY-EMBOLISM - FREQUENCY OF INTRACRANIAL HEMORRHAGE AND ASSOCIATED RISK-FACTORS, Chest, 111(5), 1997, pp. 1241-1245
ATTENUATION OVER 24 HOURS OF THE EFFICACY OF THROMBOLYSIS OF PULMONARY-EMBOLISM AMONG PATIENTS WITH CANCER
Authors: MIKKOLA KM PATEL SR PARKER JA GRODSTEIN F GOLDHABER SZ
Citation: Km. Mikkola et al., ATTENUATION OVER 24 HOURS OF THE EFFICACY OF THROMBOLYSIS OF PULMONARY-EMBOLISM AMONG PATIENTS WITH CANCER, The American heart journal, 134(4), 1997, pp. 603-607
INCREASING AGE IS A MAJOR RISK FACTOR FOR HEMORRHAGIC COMPLICATIONS AFTER PULMONARY-EMBOLISM THROMBOLYSIS
Authors: MIKKOLA KM PATEL SR PARKER JA GRODSTEIN F GOLDHABER SZ
Citation: Km. Mikkola et al., INCREASING AGE IS A MAJOR RISK FACTOR FOR HEMORRHAGIC COMPLICATIONS AFTER PULMONARY-EMBOLISM THROMBOLYSIS, The American heart journal, 134(1), 1997, pp. 69-72
Risultati: 1-3 |